Molecular Monitoring With Circulating Tumor DNA and Nivolumab Maintenance: A Pilot Study in Diffuse Large B-Cell Lymphoma
Phase of Trial: Phase 0
Latest Information Update: 17 Jan 2019
At a glance
- Drugs Nivolumab (Primary)
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 16 May 2018 Status changed from not yet recruiting to recruiting.
- 07 Feb 2018 Planned initiation date changed from 1 Jan 2018 to 1 Apr 2018.
- 04 Jan 2018 Planned initiation date changed from 1 Dec 2017 to 1 Jan 2018.